---
DrugClass: "[[Adrenergic Blocking]]"
SubClass: "[[Beta (β)-adrenergic blocking]]"
DrugClassContra: "[[Beta (β)-adrenergic blocking#Contraindications]]"
DrugClassAdverse: "[[Beta (β)-adrenergic blocking#Adverse Reactions]]"
SecondaryDrugClass: "[[Cardiotonic and Antiarrhythmic Drugs]]"
SecondarySubClass: "[[Antiarrhythmics]]"
BrandName: Betapace, Betapace AF, Sorine
Chapter: "24"
KindleLinkChap: "[Chapter 24](kindle://book?action=open&asin=B09FRF11YJ&location=12809)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
SecondaryAdverse: "[[Antiarrhythmics#Adverse Reactions]]"
SecondaryContra: "[[Antiarrhythmics#Contraindications]]"
---
```smiles
CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
```

### Brand name
`=this.BrandName`
### Generic name
`= this.file.name`
### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`
`= this.SecondaryDrugClass`
	`= this.SecondaryDrugClass.KindleLinkChap`

### Dosage & Usage
Ventricular arrhythmias (maintain normal sinus rhythm— Betapace AF only)
160– 320 mg/ day orally in divided doses
### Contraindications
See `= this.DrugClassContra`
See `= this.SecondaryContra`

### Interactions

### Side/Adverse Effects
See `= this.DrugClassAdverse`
See `= this.SecondaryAdverse`
Dizziness, hypotension, nausea, vomiting, diarrhea, [[Respiratory]] distress

### Interactions

`= this.ChemLink+this.file.name`

